Website
http://dataportal.arc.gov.au/NCGP/API/grants/DP0987570
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Drug Companies, their Patenting Strategies and High-Cost Pharmaceuticals: An Empirical Investigation. Pharmaceuticals are a vital part of clinical services that maintain and improve Australia's health; they are also costly, absorbing a substantial proportion of the national health expenditures. By conferring market protections, the patent system helps the manufacturers of pharmaceuticals to recoup the high costs of research associated with developing new products. Abuses of the patent system by pharmaceutical manufacturers have the potential to stifle competition and inappropriately raise the costs of pharmaceuticals to society. This innovative, cross-disciplinary, research will investigate the existence of abusive patents and, if necessary, propose reforms that will prevent further abuse and reduce the size of the health budget.Funded Activity Details
Start Date: 2009
End Date: 12-2016
Funding Scheme: Discovery Projects
Funding Amount: $290,000.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Clinical Pharmacology And Therapeutics | Law | Intellectual Property | Public Policy
ANZSRC Socio-Economic Objective (SEO)
Understanding legal processes | Health policy economic outcomes |
